US FDA's Hiring: First Phase Of Cures Implementation Will Focus On Senior Staff
Workforce report to Congress, mandated by 21st Century Cures Act, details FDA's plans for implementing its new authorities provided by the law.
You may also be interested in...
Lauren Silvis will leave her post as chief of staff at the US FDA in the next several weeks, when she will be replaced by associate commissioner for strategic initiatives and external affairs Keagan Lenihan.
Kathleen Uhl gave seven months' notice of her retirement, which may allow new director to be hired and on-boarded before she departs.
Uhl, who shepherded OGD into the user fee era, will retire in February.